# A Study of LY3471851 in Participants With Eczema

> **NCT04081350** · PHASE1 · COMPLETED · sponsor: **Nektar Therapeutics** · enrollment: 48 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DRUG:** LY3471851
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04081350
- **Lead sponsor:** Nektar Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-04
- **Primary completion:** 2022-06-24
- **Final completion:** 2022-06-24
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2024-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04081350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04081350, "A Study of LY3471851 in Participants With Eczema". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04081350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*